In conclusion, we have shown that in L-NAME-induced hypertension, the dual inhibition of neprilysin and AT1 receptor by ARNI reduced SBP and prevented the development of LV hypertrophy, fibrosis, and systolic and diastolic dysfunction. The gene discussed is AGTR1; the disease is hypertensive disorder.